Why an Independent Sourcing Desk Cannot Qualify Components f

Why an Independent Sourcing Desk Cannot Qualify Components for Medical Devices

An independent industrial-automation sourcing desk can supply components that go into non-implantable medical equipment, but it cannot qualify a part for use in a medical device — that judgment belongs inside the device manufacturer's quality system, not at the distributor. What the desk confirms is component identity, condition (new surplus, refurbished or used), and the documentation the source can provide; what it cannot confirm is biocompatibility, sterilisation compatibility, service life in the device's environment, or conformity under the device maker's own regulatory pathway. Expecting a sourcing partner to sign off on a part as suitable for the device is the most common source of friction between medical-device OEMs and independent distributors, and the article below lays out where the boundary sits.

The buyer profile this applies to is specific. A medical-device manufacturer building a non-implantable device — laboratory automation, diagnostic support equipment, environmental monitoring for a cleanroom, dental or surgical support kit, sterilisation conveyor control — needs industrial-automation components sourced reliably. The question is what kind of partner can honestly do that work, and where that partner's authority ends.

Data through: September 2026.

Where the line sits: supply versus qualification

The clearest way to state the boundary is to separate three jobs that are often run together in a buyer's mind. The first is procurement — locating a part, confirming what is available, getting it to the loading dock. The second is verification — confirming that the part received is what was ordered, in the stated condition, with the markings it should carry. The third is qualification — confirming that the part is fit for a particular medical application, given the device's risk class, its regulatory pathway, and the way the device is used, cleaned and serviced over its life.

An independent sourcing desk handles the first two. The third is the device manufacturer's job, and the people qualified to do it sit inside the manufacturer's quality system: the regulatory affairs function, the design controls, the validation engineers. A desk can put a Mitsubishi FX5U-32MT/DS module on a quotation, take a photograph of the marking, and confirm that the unit powers up. It cannot tell you whether that specific FX5 module, in the configuration your device ships with, satisfies the regulatory pathway your device follows — and it is the manufacturer's job to be specific about that pathway, because only the manufacturer knows what claims the device makes and what risks it carries.

This is not a courtesy disclaimer. It is the structure of how medical-device regulation actually works, and it is the reason no independent distributor holds ISO 13485: the certification describes a manufacturer's quality system, and the manufacturer is the only entity that can hold one for its own devices. If a desk offered an ISO 13485-certified claim for itself, the claim would refer to nothing — there is no certificate that turns a parts supplier into a regulated manufacturer of somebody else's device.

What qualification actually means in this context

When a medical-device OEM says a component is qualified for their device, the word is doing work that an outside observer usually underestimates. Qualification is a documented argument that the component performs as required across the device's specified use envelope — temperature, humidity, cleaning agents, sterilisation cycles if applicable, vibration, electromagnetic environment, expected service life, and the failure modes the device is designed to tolerate. The argument is built during design controls, recorded in the device history file, and signed off by people whose signatures mean something under the manufacturer's regulatory pathway.

That argument cannot be outsourced to a parts supplier. The supplier is not present during the device's design review, has not read the device's risk analysis, and cannot speak to whether the component's behaviour matters to a hazard that has been identified and mitigated elsewhere in the device. Even where the component is identical to one the manufacturer already qualified, the qualification does not travel with the part to a new application — it travels only when the manufacturer re-runs the qualification on the new application. A buyer who treats a qualified component as a transferable asset is treating documentation as fungible, and that mistake tends to show up later, not sooner.

The practical consequence is that an independent desk can source a component identical to one used in a previously qualified device, but the manufacturer still owns the qualification step on the new device. Buyers who ask the desk for a qualified component are asking the desk for a document the desk cannot honestly issue. The desk can return a quotation, a photograph, and a per-line condition statement; it cannot return a qualification record, because the desk did not build one.

What an independent desk can verify, and what it cannot

The honest capability list is short, and it is more useful to a procurement team than an inflated one.

What the desk can verify:

The component identity, as read from the marking on the unit and cross-checked against the source's documentation. A MELSEC FX5U-32MT/DS or FX5-20PG-P module, for example, can be confirmed by its label, its front-panel marking and the source's packing list.
The condition of each line — new surplus, refurbished or used — and for refurbished units, the bench test that was recorded against the unit.
Whether the line came from a channel consistent with the stock being authentic, with the caveat that "consistent with" is not a manufacturer's authentication guarantee. The desk screens for counterfeits, photographs the unit before dispatch, and refuses lines that look wrong — but the desk is not the manufacturer and does not claim to issue the manufacturer's authentication certificate.
The availability, the price and the minimum order quantity per line, with the caveat that all three move and are quoted per order rather than held from one quote to the next.

What the desk cannot verify, and will not pretend to:

Whether the component is suitable for the device's intended use, environment, or service life.
Whether the component satisfies biocompatibility, sterilisability, cleaning-agent compatibility, or any other requirement that depends on how the device is built and used.
Whether the component sits inside the device's certification scope under the manufacturer's regulatory pathway.
Whether substituting one component for another (same series, different suffix; or different brand) is acceptable for the device.

When a buyer asks for any of these, the correct response is to send the question back to the manufacturer's own quality and regulatory teams. The desk's role is to make sure the right component, in the right condition, with the right documentation, gets to the loading dock — not to substitute itself for those teams.

Why the suitability descriptor is not one the desk will use

A phrase buyers sometimes search for — and supply-side marketing sometimes offers — is a descriptor that promises the part is suitable for the device. That descriptor is not a category with a fixed meaning. Industrial-automation components carry the ratings their manufacturer states in the datasheet; whether those ratings satisfy a particular medical device is a design and regulatory question that belongs to the device manufacturer. A distributor that promises parts as suitable for the device is either borrowing the language of device-component qualification (and using it loosely) or implying that it has done the qualification work on the buyer's behalf. Both are claims the desk does not make.

What the desk does instead is report the datasheet as published: ingress protection rating if stated, ambient temperature range if stated, materials if stated, certifications the manufacturer has obtained if stated. Anything the manufacturer has not published is reported as "not stated by manufacturer" rather than filled in from a similar-looking component. The buyer can then decide whether the published figure is sufficient for the device — or whether the device's quality system requires a higher figure that only the device's design controls can demand and verify.

A useful rule of thumb for the procurement team: if a supplier is willing to call a part suitable for a medical device without the device manufacturer having qualified that specific part for that specific device, the supplier has said more than it should.

When the desk is a useful partner for a medical-device OEM

There are several real, recurring cases where the desk's capabilities line up with what a medical-device OEM actually needs to procure.

The first is sourcing for a cleanroom auxiliary — environmental monitoring, building automation for the production facility, conveyor or packaging controls outside the sterile field. These applications often use the same automation components a panel shop would specify, and they are bought as ordinary industrial components rather than as device components. A MELSEC platform controlling a sterilisation conveyor's auxiliary infeed, for example, is bought as a process control component, and the desk can source it as such.

The second is maintenance, repair and operations for an existing device that is already on the market. The OEM's service organisation needs a supply of parts that may be obsolete, allocation-constrained, or out of production at the franchised channel. The desk can find these parts across the secondary market and present them with condition stated per line.

The third is the case where the OEM has already qualified a component, the design is stable, and the procurement question is purely about availability, price and minimum order quantity. The desk's per-line quoting and per-line condition disclosure line up well with that task.

The fourth is third-party inspection and pre-dispatch evidence for a batch the OEM has sourced itself — for example, from an open-market vendor in China. The desk can act as the OEM's agent to receive the batch in Shenzhen, carry out visual and incoming inspection, and arrange third-party laboratory testing such as X-ray, decapsulation or electrical measurement. Scope, method and fee are agreed before work starts; the desk does not operate a certified laboratory of its own and does not claim tests it did not perform.

When the desk is the wrong partner

There are several cases where a medical-device OEM should not be working through an independent sourcing desk, even if the desk could technically source the part.

The first is any application where the device maker's quality system requires a manufacturer-issued warranty, a manufacturer-issued certificate of conformance, or a manufacturer-issued traceability record. The desk can supply the component; it cannot manufacture any of those documents.

The second is any application where the device's regulatory pathway requires a regulatory-body-issued certificate (CE under MDR, FDA 510(k) clearance, EAC or TR CU registration, and so on) to be on file against the specific component. The desk does not hold those certificates for components and does not apply for them on the buyer's behalf. Certification of the device is the device maker's responsibility; certification of the component against a regulator's scheme, where required, sits with the component manufacturer or with the importer.

The third is any application where the component participates in a risk-control function inside the device — the kind of function whose failure the device's risk analysis has to handle, where the device's documentation pins a specific part number, or where a substitute cannot be verified on the axes the application depends on. In those cases the right answer is to keep sourcing the original, or to treat the change as a redesign rather than a replacement. The desk will decline the request rather than guess at acceptability.

The fourth is any request that would require the desk to misrepresent a component's condition, history or documentation in order to clear a buyer's internal gate. The desk does not do this. If a buyer's internal gate requires a certificate the source cannot provide, the right answer is to change the gate — for example, by accepting the per-line condition disclosure and pre-dispatch evidence the desk provides — not to ask the desk to invent the missing document.

Used, refurbished and new surplus in the medical context

Condition matters in medical applications for the obvious reason: a device on the market carries a defined service life and a defined expectation of when its components will be replaced. Used and refurbished components are bought into the secondary market for a reason — they were pulled from service, an upgrade changed the spec, or a project was cancelled — and the buyer needs to know which it is, because each carries different implications.

A new-surplus line is unused stock sourced outside the manufacturer's franchised channel. Its markings are intact, its packaging is original, and its shelf life is whatever the manufacturer's published storage specification allows. It is the closest analogue to a franchised-channel purchase, but it does not carry a manufacturer-issued warranty unless the manufacturer confirms one for the specific lot.

A refurbished unit has been repaired or reconditioned and bench-tested, with the test result recorded against the unit. The desk reports the test that was performed and the outcome. Refurbished does not mean "as new," and it does not carry a manufacturer-issued warranty unless the manufacturer has explicitly extended one.

A used unit is pulled from service and sold as-is. The desk inspects and photographs it before dispatch, states its condition in plain language, and does not claim it has been tested unless a test record exists. Used units are appropriate for some maintenance applications and inappropriate for others; the decision is the device owner's.

The desk does not describe a used unit as refurbished, and does not describe a refurbished unit as new. The distinction matters in medical applications because the device's quality system has to make its own determination about whether the component's history is consistent with the device's service record. A line that has been pulled from a decommissioned device, for example, carries a service history that the device maker may need to consider before the component goes back into service. The desk reports the history it can confirm; the device maker decides what that history means in context.

Substitutes and cross-references in the medical context

The buyer-intent question that follows qualification is substitution. When a part is obsolete, allocation-constrained, or out of production, the procurement team asks whether a substitute will work. The answer is shaped by the same boundary that qualification sits behind: the desk can compare the substitute to the original on twelve documented axes (outline and mounting, dimensions, terminal assignment, electrical ratings, function and I/O specification, firmware and hardware version, communication protocol, mechanical parameters, environmental class, ingress and temperature, materials, and certifications and lifecycle) and report each axis as matched, differs or unknown. What the desk does not do is certify that the substitute is acceptable for the device.

The certification step belongs to the device maker's engineering and regulatory teams, who run the substitution through the same design controls that the original went through. For an FX5U module substituted by a different revision or a different series, the cross-reference table tells the engineering team what they would have to verify; the engineering team's job is to verify it. A line that touches a risk-control function, certification scope, program logic or device history is flagged as requiring engineering review rather than being replaced on the desk's authority.

This is also where the twelve-axis framework earns its keep in a medical context. The most common unknown axis is firmware_version — whether the substitute's firmware is compatible with the device's project file, or whether the device maker has to re-import the project, re-validate the I/O mapping, or re-run the qualification tests. The desk reports the axis as unknown rather than guessing; the engineering team closes the question with the device's own records.

The fail-safe case here is also worth naming plainly: when the original part participates in a risk-control function inside the device, when it sits inside a certified assembly whose scope would change, when the machine's own documentation pins the design to a specific part, or when the substitute cannot be verified on the axes the application depends on, do not substitute at all on the desk's authority. The substitution decision belongs to the device maker, and verify against the original manufacturer datasheet and your own qualification process.

What the desk will not say, even if you ask

There are several statements the desk will not make, in writing or in conversation, regardless of how the request is framed. They are not negotiable because they are not within the desk's authority to make.

The desk will not describe itself as an authorised distributor, a franchisee, or a partner of any manufacturer. It is an independent sourcing desk, and the line on this is firm.

The desk will not hold itself out as ISO 13485 certified. It does not hold the certification, and the certification does not apply to a parts supplier in the way some buyers assume. If a buyer's quality system requires that certification, the right partner is a qualified supplier, not an independent desk.

The desk will not certify a component as suitable for a particular medical application, as biocompatible, as sterilisable, or as appropriate for the device's regulatory pathway. The datasheet's published ratings are reported; everything else is left to the manufacturer's quality system.

The desk will not arrange EAC, TR CU, CE under MDR, FDA 510(k) or any other regulatory certification on the buyer's behalf. Conformity assessment for the device is the device maker's responsibility, and the desk does not provide advice on the regulatory question.

The desk will not decline a request to source a component because of the medical application, and it will not misrepresent the application to a source either. Sourcing decisions on the desk's side are made on what the desk is and is not, not on the buyer's application.

Delivery to Russia and the CIS is arranged under EXW, FCA, DAP or DDP, with the term stated on the quotation; the desk does not announce a fixed transit time, a weekly consolidated air-freight line, or a domestic presence in Russia. The desk does screen end users and end uses, classifies before quoting, and declines transactions that cannot be screened.

What the desk does next, after the boundary is clear

When the boundary is clear, the procurement workflow for a medical-device OEM is not very different from the procurement workflow for any other industrial buyer — provided the right team owns each step.

The OEM's regulatory and quality teams own the qualification step. They decide which components are qualified for which devices, in which configurations, under which regulatory pathway, and they sign off on the design history file. They also decide whether a used or refurbished component is acceptable for a given maintenance task.

The OEM's procurement team owns the sourcing step. They choose the channel, manage the relationship, confirm the order, and arrange the documentation. If the procurement team chooses an independent sourcing desk, the desk takes the order line by line, confirms condition and availability, photographs the goods before dispatch, and supplies the commercial documentation that the procurement team needs for import and accounting.

The OEM's engineering team owns the substitution decision. If a component is obsolete, allocation-constrained, or out of production, the engineering team decides whether a substitute is acceptable, on which axes the substitute must match, and whether the substitution requires a re-qualification under the manufacturer's quality system. The desk provides a cross-reference table for the engineering team to work from, with the axes reported as matched, differs or unknown. The decision is not the desk's.

This division is what allows an independent sourcing desk to be useful in medical-device procurement without misrepresenting what it is. The desk does what it can do honestly, and the rest is done by the teams that are qualified to do it.

Data Notes

This article is grounded in the desk's published service scope (/quality, /procurement, /about, /shipping-returns, /terms-of-sale) and in the catalog entries for Mitsubishi MELSEC platforms cited above (FX5U-32MT/DS, FX5-4LC, FX5-20PG-P, FX5-20PG-D, R60AD8-G). The boundary statements about ISO 13485, regulatory certification and risk-control substitution reflect what is and is not an independent distributor's authority, not a judgement about any specific manufacturer's component. No external news or market data was used in this piece.

The takeaway

If you build non-implantable medical equipment and need a sourcing partner for components, an independent desk can supply the components, state their condition per line, send pre-dispatch photographs and arrange third-party inspection where it is useful. It cannot qualify a component for your device, certify it as suitable for the device, or hold ISO 13485 — and any partner who says it can is not describing what they actually do. The desk's value to a medical-device OEM is that it does what a distributor can honestly do, and refuses the rest, so the rest stays with the teams that own it.

For an OEM whose quality system requires an authorised distributor, ISO 13485, or a regulatory certificate on file against the specific component, the right partner is a qualified supplier, not an independent desk. Send the BOM and the requirement through the desk's procurement page (/procurement) and the inquiry form (/inquiry), and we will tell you which lines the desk can quote and which lines belong with a different partner.

FAQ

Can an independent distributor supply components for non-implantable medical devices?

Yes. The desk sources industrial-automation components that medical-device manufacturers use in the equipment they build. What the desk does not do is qualify a component for a specific medical application — that judgment sits inside the device maker's quality system, with the regulatory and design-controls functions. The desk reports the component, its condition (new surplus, refurbished or used), and the documentation the source can provide; the device maker's team decides whether the component is acceptable for the device.

Are the components you sell suitable for medical devices?

No, and that label is not one the desk uses. Industrial-automation components carry the ratings their manufacturer states in the datasheet; whether those ratings satisfy a particular medical device depends on the device, its risk class, and the manufacturer's regulatory pathway. The desk reports what the datasheet says and marks the rest as not stated by manufacturer, so the device maker's quality system can make its own determination.

Do you hold ISO 13485?

No. The desk is an independent sourcing desk, not a medical-device manufacturer, and ISO 13485 certifies a manufacturer's quality system. If your quality system requires that certification, the part should be sourced through a qualified supplier; the desk will tell you which lines it can quote and which lines belong with a different partner.

Can I buy used or refurbished parts for medical equipment from you?

Used and refurbished parts are available for maintenance and repair work, with condition stated per line and pre-dispatch photographs for used and refurbished lines. Whether a used or refurbished component is acceptable in a particular medical device is a decision for the equipment owner's quality system, not for the desk. The desk does not describe a used unit as refurbished, and does not describe a refurbished unit as new — the distinction has to be honest because the device maker's quality system depends on it.

Can you certify that a substitute will work in our device?

No. Substituting one component for another (same series, different suffix; or different brand) is a design change that requires qualification under the device maker's quality system, and only the device maker can run that qualification. The desk can produce a cross-reference table with axes reported as matched, differs or unknown — that is a comparison, not a certification. The decision belongs to the device maker's engineering and regulatory teams, and verify against the original manufacturer datasheet and your own qualification process.

Can you help us get EAC, CE under MDR or FDA clearance for a component?

No. The desk does not hold regulatory certificates for components, does not apply for them on a buyer's behalf, and does not advise on which regulatory pathway a device follows. Conformity assessment for the device is the device maker's responsibility, and the desk's role ends with the commercial documentation it issues at quotation stage.

Can you act as our inspection agent in China if we source a batch ourselves?

Yes. Where the buyer has sourced a batch themselves from an open-market vendor or their own supplier in China, the desk can act as their agent on the ground: receive the batch, carry out visual and incoming inspection, and arrange third-party laboratory testing such as X-ray, decapsulation or electrical measurement. Scope, method and fee are agreed before work starts; the desk does not operate a certified laboratory of its own and does not claim tests it did not perform.